Emily Goodlander represents clients in product liability and mass tort litigation matters. She has played a lead role in defending major pharmaceutical and medical device manufacturers, including vaccine-related litigation. Emily has also coordinated a multi-million-dollar budget for nationwide pharmaceutical litigation. She leverages her background in bioethics when translating complex scientific concepts.
Well versed in the discovery process, Emily has experience performing company document review in connection with deposition preparation, document production and litigation chronologies. She has crafted document review protocols, managed discovery workflows, prepared privilege logs and drafted chronologies. Emily managed the discovery process in multi-district litigation and two state-coordinated proceedings, involving over 2,000 plaintiffs bringing personal injury claims related to a vaccine.
She has been instrumental in trial proceedings, with experience managing attorneys in complex multi-district litigation. She regularly supports trial teams, contributes to strategic legal research, and collaborates closely with attorneys across disciplines in high-exposure matters. She has scoured hundreds of scientific publications, drafting fact sheets and memoranda explaining their results. Emily engages in rigorous witness research, interviewing company witnesses, assisting in expert development, and analyzing opposing expert testimony.
Trial teams look to Emily for her creativity in problem solving and attention to detail. She has supported senior attorneys in all stages of motions practice, including motions in limine, motions for summary judgment, Daubert motions and trial briefs. Notably, Emily was the primary author of a successful appellate brief on behalf of three global vaccine manufacturers.
Community is important to Emily; she offers pro bono legal services through a social justice organization providing legal assistance for LGBTQ+ clients. She also enjoys cooking with friends and cheering on the Orioles.